CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±èÀº°æ
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ¸¸¼ºÆó¼â¼ºÆóÁúȯ, Æó°áÇÙ, °£Áú¼ºÆóÁúȯ, Æó¾Ï
  • Á÷ À§: ºÎ±³¼ö
  • ¸Þ ÀÏ:
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
108 (±¹¿Ü)SCIE Urinary desmosine is associated with emphysema severity and frequent exacerbation in patients with COPD
107 (±¹¿Ü)SCI An association between periostin levels with the severity and chronicity of atopic dermatitis in children
106 (±¹¿Ü)SCIE Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
105 (±¹³»)SCIE Clinical Characteristics of Exacerbation-Prone Adult Asthmatics Identified by Cluster Analysis
104 (±¹¿Ü)SCIE Clinical Implications of Oscillatory Lung Function during Methacholine Bronchoprovocation Testing of Preschool Children
103 (±¹¿Ü)SCIE Poor sleep quality has an adverse effect on childhood asthma control and lung function measures
102 (±¹³»)KCI ºñ¿°Á¶ÀýÆò°¡°Ë»çÀÇ Çѱ¹¾î Àû¿ë
101 (±¹³»)SCOPUS ÀÓ»óÀǸ¦ À§ÇÑ ¾Ë·¹¸£±âºñ¿° Áø·áÁöħ: Æ÷°ýÀû Ä¡·á ¹× Ư¼ö»óȲ¿¡ ´ëÇÑ °í·Á
100 (±¹¿Ü)SCIE Efficacy and safety of indacaterol/ glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial
99 (±¹³»)SCOPUS ÀÓ»óÀǸ¦ À§ÇÑ ¾Ë·¹¸£±âºñ¿° Áø·áÁöħ: ³»°úÀû Ä¡·á
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729